Sentinel lymphadenectomy in thyroid malignant neoplasms

Archives of Surgery

Volumn 133, Issue 3, 1998, Pages 288-292

  Kelemen, Pond R ^a   Van Herle, Andre J ^b   Giuliano, Armando E ^a,b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THYROID CANCER; THYROID NODULE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031969679     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.3.288     Document Type: Article

References (27)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1997. CA Cancer J Clin. 1996;47:5-27.
2. Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am. 1987;67:251-261.
3. Tubiana MM, Rougier P, Laplanche A, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794-804.
4. Hamby LS, McGrath PC, Schwartz RW, Sloan DA, Simpson WG, Kenady DE. Management of local recommences in well differentiated thyroid carcinoma. J Surg Res. 1992;52:113-117.
5. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428.
6. Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery. 1985;98:1171-1178.
7. Hay ID, Taylor WF, McConahey WM. A prognostic score for predicting outcome in papillary thyroid carcinoma. Endocrinology. 1986;119(suppl):T-15. Abstract.
8. Cady B, Rossi R. An expanded review of risk group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953.
9. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424.
10. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 1995;118:1131-1138.
11. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of trreatment of well-differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720.
12. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg. 1978;136:107-110.
13. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differential thyroid cancer. Am J Surg. 1991;162:353-356.
14. Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastasis in differentiated thyroid cancer. Am J Surg. 1992;164:578-581.
15. Byar DP, Green SB, Doc P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15:1033-1041.
16. McGregor GI, Luoma A, Jackson SM. Lymph node metastasis from well-differentiated thyroid cancer: a clinical review. Am J Surg. 1985;149:610-612.
17. Morton DL, Wen DR, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am. 1992;1:247-259.
18. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 1994;220:391-410.
19. Noguchi M, Kumaki T, Taniga T, et al. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multifactorial analysis of 218 cases. Int Surg. 1990;75:220-224.
20. Hamming JF, Van De Velde CJH, Fleuren GJ, Goslings BM. Differentiated thyroid cancer: a stage-adapted approach to the treatment of regional lymph node metastasis. Eur J Cancer Clin Oncol. 1988;24:325-330.
21. Ballantyne AJ. Neck dissection for thyroid cancer. Semin Surg Oncol. 1991;7: 100-106.
22. Coburn M, Teates D, Wanebo HJ. Recurrent thyroid cancer: role of surgery versus radioactive iodine. Am Surg. 1994;219:587-595.
23. Silverberg SG, Hutter RVP, Foote FW Jr. Fatal carcinoma of the thyroid: histology, metastasis, and causes of death. Cancer. 1970;25:792-802.
24. McGregor GI, Luoma A, Jackson SM. Lymph node metastasis from well-differentiated thyroid cancer: a clinical review. Am J Surg. 1985;149:610-612.
25. Cady B, Sedgewick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer. 1979;43:810-820.
26. 131I therapy for well-differentiated thyroid cancer, a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med. 1992;33:1132-1136.
27. Ellenhorn JDI, Shah JP, Brennan MF. Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery. 1993;114: 1078-1082.